Pre-ART retention in care and prevalence of tuberculosis among HIV-infected children at a district hospital in southern Ethiopia

BMC Pediatrics

Bernt Lindtjørn³  Inger Hallström⁴  Zewdie Mulissa²  Degu Jerene¹  Emil Westerlund⁴ 

[1]Management Sciences for Health-HEAL TB Project, Addis Ababa, Ethiopia

[2]Columbia University- International center for AIDS care and treatment program, Addis Ababa office, Addis Ababa, Ethiopia

[3]Centre for International Health, University of Bergen, Bergen, Norway

[4]Faculty of Medicine, Lund University, Lund, Sweden

关键词: WHO;    Resource-limited;    Arba Minch;    ART;    Children;    Ethiopia;    TB;    HIV;   

Others  :  1121245
DOI  :  10.1186/1471-2431-14-250

 received in 2014-03-28, accepted in 2014-09-23,  发布年份 2014

【 摘 要 】

Background

The Ethiopian epidemic is currently on the wane. However, the situation for infected children is in some ways lagging behind due to low treatment coverage and deficient prevention of mother-to-child transmission. Too few studies have examined HIV infected children presenting to care in low-income countries in general. Considering the presence of local variations in the nature of the epidemic a study in Ethiopia could be of special value for the continuing fight against HIV. The aim of this study is to describe the main characteristics of children with HIV presenting to care at a district hospital in a resource-limited area in southern Ethiopia. The aim was also to analyse factors affecting pre-ART loss to follow-up, time to ART-initiation and disease stage upon presentation.

Methods

This was a prospective cohort study. The data analysed were collected in 2009 for the period January 2003 through December 2008 at Arba Minch Hospital and additional data on the ART-need in the region were obtained from official reports.

Results

The pre-ART loss to follow-up rate was 29.7%. Older children (10–14 years) presented in a later stage of their disease than younger children (76.9% vs. 45.0% in 0–4 year olds, chi-square test, χ2 = 8.8, P = 0.01). Older girls presented later than boys (100.0% vs. 57.1%, Fisher’s exact test, P = 0.02). Children aged 0–4 years were more likely to be lost to follow-up (40.0 vs. 21.8%, chi-square test, χ2 = 5.4, P = 0.02) and had a longer time to initiate ART (Cox regression analysis, HR: 0.50, 95% CI: 0.25-0.97, P = 0.04, controlling for sex, place of residence, enrolment phase and WHO clinical stage upon presentation). Neither sex was overrepresented in the sample. Tuberculosis prevalence upon presentation and previous history of tubercolosis were 14.5% and 8% respectively.

Conclusions

The loss to follow-up is alarmingly high and children present too late. Further research is needed to explore specific causes and possible solutions.

【 授权许可】

   
2014 Westerlund et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Joint United Nations Programme on HIV/AIDS: Global report: UNAIDS report on the global AIDS epidemic 2013. 2013.
• [2]Joint United Nations Programme on HIV/AIDS: Global report: UNAIDS report on the global AIDS epidemic 2012. 2012.
• [3]Rosen S, Fox MP: Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011, 8(7):e1001056.
• [4]Ethiopian Health and Nutrition Research Institute Federal Ministry of Health: HIV Related Estimates and Projections for Ethiopia - 2012. Addis Ababa; 2012.
• [5]Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W: Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. PLoS Med 2009, 6(4):e1000056.
• [6]Mulissa Z, Jerene D, Lindtjørn B: Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS One 2010, 5(10):e13268.
• [7]Ahmed I, Gugsa ST, Lemma S, Demissie M: Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study. BMC Public Health 2013, 13:867. BioMed Central Full Text
• [8]Jerene D, Endale A, Lindtjørn B: Acceptability of HIV counselling and testing among tuberculosis patients in south Ethiopia. BMC Int Health Hum Right 2007, 7:4. BioMed Central Full Text
• [9]Joint United Naitons Programme on HIV/AIDS: Global Report: Fact sheet. 2010.
• [10]Berhan Y: Age and CD4 count of vertically HIV-infected children at the time of diagnosis: what are independent predictors for being symptomatic and CD4 counts drop? J Trop Pediatr 2011, 57(1):14-23.
• [11]Gomber S, Kaushik JS, Chandra J, Anand R: Profile of HIV infected children from Delhi and their response to antiretroviral treatment. Indian Pediatr 2011, 48(9):703-707.
• [12]Mugavero MJ: Improving engagement in HIV care: what can we do? Topics in HIV medicine: a publication of the International AIDS Society, USA 2008, 16(5):156-161.
• [13]Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L: Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009, 4:5.
• [14]Mirza A, Rathore MH: Pediatric HIV infection. Adv Pediatr 2012, 59(1):9-26.
• [15]Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA: Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquired Immune Deficiency Syndromes (1999) 2009, 52(2):280-289.
• [16]Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R: Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008, 13(7):904-913.
• [17]Mojumdar K, Vajpayee M, Chauhan NK, Mendiratta S: Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. BMC Public Health 2010, 10:416. BioMed Central Full Text
• [18]Ministry of Health: Guidelines for use of antiretroviral drugs in Ethiopia. Addis Ababa: Ministry of Health; 2003.
• [19]Ministry of Health: Guideline for use of Antiretroviral drugs in Ethiopia. Addis Ababa; 2005.
• [20]Ministry of Health: Guidelines for Paediatric HIV/AIDS Care and Treatment in Ethiopia. Addis Ababa: Ministry of Health; 2008.
• [21]von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61(4):344-349.
• [22]Joint United Nations Programme on HIV/AIDS: Global report: UNAIDS report on the global AIDS epidemic 2010. 2010.
• [23]Boender TS, Sigaloff KCE, Kayiwa J, Musiime V, Calis JCJ, Hamers RL, Nakatudde LK, Khauda E, Mukuye A, Ditai J, Geelen SP, Mugyenyi P, de Wit TF R, Kityo C: Barriers to initiation of pediatric HIV treatment in uganda: a mixed-method study. AIDS Res Treatment 2012, 2012:817506.
• [24]Singh S, Jat KR, Minz RW, Arora S, Suri D, Sehgal S: Clinical profile of 516 children affected by HIV in a tertiary care centre in northern India: 14 years of experience. Trans R Soc Trop Med Hyg 2009, 103(6):627-633.
• [25]Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P: International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 2007, 370(9581):68-80.
• [26]Kassa A, Teka A, Shewaamare A, Jerene D: Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg 2012, 106(6):363-370.
• [27]Elenga N, Kouakoussui KA, Bonard D, Fassinou P, Anaky M-F, Wemin M-L, Dick-Amon-Tanoh F, Rouet F, Vincent V, Msellati P: Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study. Pediatr Infect Dis J 2005, 24(12):1077-1082.